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Edited by Horst FeldmannAbstract Analysis of several Saccharomyces cerevisiae ump
mutants with defects in ubiquitin (Ub)-mediated proteolysis
yielded insights into the regulation of the polyubiquitin gene
UBI4 and of proteasome genes. High-molecular weight Ub–
protein conjugates accumulated in ump mutants with impaired
proteasome function with a concomitant decrease in the amount
of free Ub. In these mutants, transcriptional induction of UBI4
was depending in part on the transcription factor Rpn4. Deletion
of UBI4 partially suppressed the growth defects of ump1
mutants, indicating that accumulation of polyubiquitylated
proteins is deleterious to cell growth. Transcription of protea-
some subunit genes was induced in ump mutants aﬀecting the
proteasome, as well as under conditions that mediate DNA
damage or the formation of abnormal proteins. This induction
required the transcriptional activator Rpn4. Elevated Rpn4 levels
in proteasome-deﬁcient mutants or as a response to abnormal
proteins were due to increased metabolic stability. Up-regulation
of proteasome genes in response to DNA damage, in contrast, is
shown to operate via induction of RPN4 transcription.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Selective ubiquitin (Ub)-mediated proteolysis (UMP) is the
dominating mechanism in the degradation of cytosolic and
nuclear proteins in eukaryotic cells [1–3]. In this process, a
substrate is tagged with a polyUb chain that mediates inter-
action with and degradation by the proteasome [4]. The
functions of UMP range from a participation in protein
quality control to the often timed and spatially controlled
degradation of numerous regulatory proteins, including key
cell cycle regulators and many transcription factors [1]. UMP
is essential for viability of eukaryotic cells and it is becoming
increasingly clear that malfunctions within the system are
involved in the pathogenesis of severe human diseases [3].
To study the machinery involved in Ub-mediated proteoly-
sis, we selected ump mutants with defects in this process. Two
of the mutations directly aﬀected proteasome subunits, one led
to the loss of a proteasome maturation factor, the fourth one* Corresponding author.
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tants yielded insights into cellular buﬀer systems that com-
pensate for changes in Ub levels or available proteasome
capacity.2. Materials and methods
2.1. Isolation of ump mutants
A selection-based screen that yielded umpmutants and the cloning of
UMP1 encoding a proteasome maturation factor has been described
previously [5]. ump2-1 is an allele of PUP1 with a mutation leading to
an exchange from Ala to Glu at position 130. The proteolytic defects
of the ump3-1 mutant were complemented by yeast genomic library
plasmids containing the UBI4 gene or the DOA4 gene. ump4-1 is an
allele of PRE4 containing a single point mutation leading to an ex-
change from Ser to Tyr at position 224.
2.2. Construction of yeast strains and plasmids
Strains expressing C-terminally 2xha (inﬂuenza virus hemagglutinin)
tagged versions of the proteasome subunit b5/Pre2 instead of its un-
tagged counterpart were constructed as described previously [5].
Strains expressing a C-terminally 3xha tagged variant of Rpn4 were
constructed by a PCR-based method that used plasmid pFA-6a-3xha-
HIS3-MX6 as a template [6]. The ubi4-D::LEU2 strain has been
described [9]. Replacement of RPN4 with the HIS3 marker was per-
formed by an analogous strategy using plasmid pFA-6a-HIS3-MX6 as
a template [6].
2.3. Determination of protein stability after expression shut-oﬀ
(cycloheximide chase)
Yeast cells were grown at 30 C either in YPD or SD liquid media to
an OD600 of 0.8–1.2. Cycloheximide was added to each culture to a
ﬁnal concentration of 100 lg/ml. At the time points indicated in the
ﬁgures, cell samples were withdrawn and extracts prepared by glass
bead lysis in a buﬀer containing 50 mM Na–HEPES, pH 7.5, 150 mM
NaCl, 5 mM EDTA, 1% Triton X-100 and ‘‘Complete Protease-
Inhibitor cocktail’’ (Roche). Equal amounts of proteins were analyzed
by SDS–PAGE and Western blotting.
2.4. RNA isolation and Northern-blot analysis
Yeast cells were grown at 30 C in liquid YPD or SD medium to an
OD600 of 0.8–1.2. Total RNA was prepared using the RNeasy kit
(Qiagen). Northern-blot analysis of 10 lg RNA samples was carried
out as described previously [7]. Radioactive signals were quantiﬁed on
a Bio-Imaging Analyzer (Fujiﬁlm BAS 1500).3. Results and discussion
To study the genetics and physiology of selective UMP, we
isolated and analyzed ump mutants with defects in this process.blished by Elsevier B.V. All rights reserved.
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ump4) were isolated. In contrast to wild-type cells, these mu-
tants were unable to eﬃciently degrade substrates of the Ub-
dependent N-end rule and UFD pathways [8,9] (data not
shown). Both the ump1 and the ump3 mutants were severely
hypersensitive to stresses such as heat and high concentrations
of amino acid analogs or heavy metals, conditions known to
elicit an increased generation of abnormal proteins, which are
substrates of the Ub/proteasome pathway. The mutants ump2
and ump4 were less sensitive to such stresses (data not shown).
One of these mutants (ump1) lacked a proteasome maturation
factor as reported previously [5]. The ump2 and ump4 muta-
tions, both of which aﬀected the maturation (Fig. 2A) and
activity of the proteasome, were mapped to the PUP1 andFig. 1. Ub homeostasis in wild-type and umpmutant strains. A: Levels of Ub
were analyzed by anti-Ub Western blotting. To detect free Ub, the lower par
part of the gel was carried out for 1 h. B: Deletion of UBI4 or DOA4 partially
as in (A) but with a congenic set of wt, ubi4-D ump1-D and ubi4-D ump1-D str
is the complementation of the temperature sensitivity of ump3 by plasmid-en
vector control. E: Increased UBI4 and PRE2 transcript levels in ump mutants
(E). Signals for UBI4 and PRE2 were normalized to those of ACT1. mRNA v
set to 1.PRE4 genes encoding subunits b2 and b7 of this protease,
respectively. The ump3 mutation aﬀected the deubiquitylating
enzyme Doa4 [11]. The ﬁndings from the analyses of these
mutants are the following.
3.1. Ump mutants and ubiquitin homeostasis
Analysis of cell extracts by anti-Ub immunoblotting re-
vealed a striking accumulation of high-molecular weight Ub
conjugates in ump1, ump2, and ump4, while at the same time
levels of free Ub were reduced (Fig. 1A). Consistent with a
defect in the degradation of such conjugates, in all of these
mutants either the biogenesis or function of the proteasome is
aﬀected (see above). To determine whether the decreased
availability of Ub in these mutants contributed to the observedconjugates and of free Ub in extracts of wild-type and umpmutant cells
t of the gel was blotted for 10 min. Transfer of proteins from the upper
suppressed the growth defects of ump1-D C: Shown is the same analysis
ains. D: The UBI4 gene is a suppressor of the ump3-1 mutation. Shown
coded DOA4 (pDOA4) or UBI4 (pUBI4). Plasmid YCp50 served as a
detected by Northern blotting. F: Quantitation of the results shown in
alues in umpmutants were calculated relative to those in wt, which were
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which encodes the poly-Ub precursor of Ub, exacerbated or
alleviated the phenotypes of the ump1-D mutant [5]. Surpris-
ingly, ubi4-D partially suppressed the growth defects of the
ump1-D strain, while in contrast increasing the synthesis of Ub
by ectopic expression exacerbated these defects (Fig. 1B and
data not shown). An anti-Ub Western blot revealed a less
dramatic accumulation of Ub-protein conjugates in the ump1-
D ubi4-D double mutant in comparison to the ump1-D single
mutant (Fig. 1C). Taken together, these data indicated that an
accumulation of Ub-protein conjugates underlies or at least
contributes to the growth defects of the ump1-D mutant.
Consistent with this assumption, we also obtained a partial
suppression of the ump1-D growth defects when we introduced
the doa4-D mutation (Fig. 1B), which interferes with Ub re-
cycling and therefore reduces the availability of Ub for con-
jugation (see below). Comparable results were obtained for the
ump2 mutation, which was also partially suppressed both by
ubi4-D and doa4-D (data not shown). A possible explanation
for the observed detrimental eﬀects of polyubiquitylated pro-
teins accumulating in proteasome-deﬁcient mutants is that
they may sequester chaperones, which are required for protein
folding and refolding. Another possibility is that accumulating
conjugates may exert their growth-inhibitory eﬀect by blocking
the already impaired proteasome.
In contrast to the other ump mutants, we detected reduced
levels of both free and conjugated Ub in the ump3 mutant
(Fig. 1A). Cloning of genes that complemented the defects of
the ump3 mutation resulted in the isolation of the UBI4 and
DOA4 genes (Fig. 1D). Genetic analysis revealed that UMP3 is
identical to DOA4, while UBI4 appears to be a dose-dependent
suppressor of ump3/doa4. The double mutant doa4-D ubi4-D,
however, did not display a severe reduction of exponential
growth rates when compared to the doa4-D mutant but was
extremely starvation sensitive (data not shown). These results
showed that expression of the other Ub encoding genes UBI1-
UBI3 is insuﬃcient to maintain a level of free Ub high enough
to allow ump3 mutant cells to survive at 37 C or starvation
conditions. It was reported that the half-life of Ub is signiﬁ-
cantly reduced in doa4-D cells because a signiﬁcant fraction of
conjugated Ub is degraded by the proteasome as well as by
vacuolar proteases along with its substrates [11]. Consistent
with this, our data showed that cells lacking the Ub-recycling
function of Doa4 were unable to maintain normal levels of Ub
although they showed increased expression of UBI4 compared
to wild-type cells (Fig. 1E and F). The latter data demon-
strated that UBI4 expression is subject to a feedback control
that appears to mediate a response to reductions in the level of
free Ub. An induction of UBI4 was also detected in protea-
some-deﬁcient ump mutants. In these mutants, the up-regula-
tion of UBI4 expression depended in part on the transcription
factor and proteasome substrate Rpn4 (see next section). In-
duction of UBI4 is apparently detrimental to mutants impaired
in proteasome function as it contributes to the accumulation of
polyubiquitylated proteins (see above).
3.2. Impaired proteasome function results in a transcriptional
feedback regulation of proteasome gene expression mediated
by the transcription factor Rpn4
During the analysis of ump2 and ump4 mutants, both of
which are defective in proteasome maturation and function
(see above), we observed an increase in the steady state levelsof proteasome subunits (Fig. 2A). An analysis of proteasome
gene mRNAs revealed that this regulation occurred at the level
of transcription (Fig. 2A). Recently, it was reported that Rpn4
acts as a transcriptional activator of proteasome gene expres-
sion by binding to so-called PACE (Proteasome associated
control element) sequences that are found in the promoters of
proteasome subunit genes as well as genes of the Ub system
such as UBA1 and UBI4 [12]. It was subsequently shown that
Rpn4 itself is a substrate of the proteasome, suggesting that it
is a key component in feedback regulation of the proteasome
[13]. To test whether Rpn4 is indeed underlying the increased
expression of proteasome genes detected in some of our ump
mutants, we deleted the RPN4 gene in wild-type and ump
mutant strains. The most drastic eﬀect of rpn4-D was observed
in combination with ump1-D. Tetrad analysis revealed that
these two mutations are synthetically lethal (Fig. 2B). The
ump2 rpn4-D and ump4 rpn4-D double mutants showed strong
synthetic growth defects already at 30 C. In addition, they
were highly sensitive to elevated temperature and conditions
resulting in increased amounts of abnormal proteins (Fig. 2C).
Our studies also revealed that Rpn4-mediated up-regulation of
proteasome levels will often compensate primary defects in the
proteasome, many of which might thus have escaped detection
in phenotype-based assays. A deletion of the last 19 residues of
the b7/Pre4 subunit, for example, caused a decrease in pro-
teasome assembly and post-acidic activity, but did not lead to
detectable growth defects [14]. However, when combined with
a deletion of RPN4, this mutation resulted in a severe reduc-
tion in growth rates and viability (Fig. 2D).
In order to determine the importance of Rpn4 to the gen-
eration of basal levels of proteasomes under non-stressed
conditions, we compared the proteasomal chymotryptic ac-
tivity of congenic wild-type and rpn4-D strains. The rpn4-D
mutation resulted in a reduction of this activity by 50%
(Fig. 2E), indicating that Rpn4 contributes signiﬁcantly to the
synthesis of basal levels of proteasomes. This reduction,
however, does not appear to be detrimental for growth under
non-stressed conditions (Fig. 2C). To determine whether the
observed phenotypic eﬀects of rpn4-D in ump mutant back-
grounds could indeed be correlated to changes in the tran-
scription rates of proteasome genes, we analyzed and
quantiﬁed their mRNA levels by Northern-blot analysis. The
results shown in Fig. 3 clearly established that ump2 and ump4
mutants are unable to up-regulate proteasome gene expression
if they are lacking Rpn4. In addition, these double mutants
showed a signiﬁcantly reduced induction of UBI4 transcription
when compared to the ump2 and ump4 single mutants (Fig. 3).
Rpn4 control of Ub expression is consistent with a previous
report in which a PACE sequence was identiﬁed in the pro-
moter of the UBI4 gene [12].
The model of Rpn4-mediated feedback regulation of pro-
teasome gene expression implicated a stabilization of Rpn4 as
a result of impaired proteasome function. It was reported
earlier by others that Rpn4 is stabilized in proteasome mutants
and that degradation of Rpn4 seems not to involve ubiquity-
lation [13]. To conﬁrm the relevance of the above-mentioned
model to the observations made in our ump mutants, we
therefore analyzed the level of epitope-tagged Rpn4 in these
strains. Indeed, we found that steady state levels of Rpn4 were
increased in ump1, ump2 and ump4, but not in ump3 strains
(Fig. 4A). As described above, the ump3 mutation leads to a
reduction of the level of free Ub and thereby presumably does
Fig. 2. Up-regulation of proteasome levels in ump mutants requires Rpn4. A: Elevated levels of b5/Pre2 were detected in crude extracts from ump2
and ump4 strains expressing Pre2-ha by anti-ha Western blotting (upper panel). p, Prob5 precursor; i, incompletely processed b5; m, mature b5. The
lower panel shows the detection of increased PRE2 transcript levels in the same mutants by Northern blotting. B: rpn4-D and ump1-D are syn-
thetically lethal. Tetrads of strain ML3 (ump1-D::HIS3 rpn4-D::LEU2) were dissected on YPD, and viable spore clones were analyzed for histidine
and leucine prototrophy. No viable His+ Leu+ spore clones were obtained (not shown). NPD, non-parental ditype; PD, parental ditype; T, tetratype.
C: Deletion of RPN4 in the ump2 and ump4 mutants leads to strong synthetic growth defects and hypersensitivity to stresses. Serial dilutions of cells
were spotted onto plates containing YPD medium with or without 30 lMCdCl2 and incubated for 2 days. D: Up-regulation of proteasome levels by
Rpn4 masks the eﬀect of the pre4-DC19 mutation. Serial dilutions of cells were spotted onto YPD plates and incubated for 2 days. E: RPN4 is
required to maintain proteasome levels under normal growth conditions. Shown are the proteasomal chymotryptic activities in crude extracts. Values
are the means of four independent measurements. S.D. are indicated.
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degradation. The strong induction of UBI4 transcription ob-
served in ump3 (Fig. 1F) therefore appears not to depend on
increased levels of Rpn4, indicating that the polyUb gene is
under multiple controls including the one mediated by Rpn4
[15,16].
To conﬁrm that an increased half-life is underlying the
higher steady state levels of Rpn4 observed in the ump1 and
ump2 mutants, we followed its stability using expression shut-
oﬀ experiments. The data presented in Fig. 4B and quantiﬁed
as shown in Fig. 4E demonstrated that Rpn4 is degraded less
eﬃciently in these mutants (t1=2  16 and 10 min in ump1 and
ump2, respectively) than in wild-type cells, in which its turn-
over is very rapid (t1=2  2 min). Note that much shorter chase
time points were chosen for wild-type (wt) than for the mu-
tants. The still relatively short half-life of Rpn4 in these mu-
tants, which are severely impaired in the degradation of otherproteasome substrates [5], may be due to its unique Ub-inde-
pendent mode of degradation. Stress conditions leading to an
accumulation of misfolded or damaged abnormal proteins
may also require increased proteasomal activity. Therefore, we
tested whether the addition of the arginine analog canavanine
aﬀects Rpn4 levels. Within minutes after addition of 1.5 lg/ml
canavanine to an exponentially growing yeast culture, cellular
levels of Rpn4 increased, whereas in untreated control cells the
level of Rpn4 remained unchanged (Fig. 4C). Thirty minutes
after the addition of canavanine, the level of Rpn4 started
already to decrease again reaching the starting level after 60
min. Presumably, proteasomes had increased to a level that
enabled the cells to cope with the situation and to adjust a new
balance between Rpn4 degradation and the level of protea-
somes. Expression shut-oﬀ experiments showed that cana-
vanine treatment leads to increased stability of Rpn4
(Fig. 4D). Stabilization of Rpn4 was most likely due to an
Fig. 4. Defects and overloading of the proteasome induce elevated
cellular Rpn4 levels by aﬀecting its metabolic stability. A: Rpn4-ha
steady state levels in wild-type and ump mutant strains were detected
by anti-ha Western blotting. B: Rpn4-ha stability was detected after
shutting oﬀ expression using cycloheximide. C: Overloading of the
proteasome with abnormal proteins leads to an increased level of
Rpn4. Strain ML26-2B (Rpn4-ha) was grown to mid-logarithmic
phase in SD medium lacking arginine. 1.5 lg/ml canavanine was added
to one half of the culture and cells were withdrawn at the indicated
time points. Levels of Rpn4-ha were detected by anti-ha Western
blotting. D: Increased stability of Rpn4 in cells treated with cana-
vanine. Cells were grown as in (C). Rpn4 stability was determined by
expression shut-oﬀ analysis as in (B) except that 1.5 lg/ml canavanine
was added 25 min prior to cycloheximide addition. E: Quantitation of
Rpn4-ha signals shown in (B) (open symbols) and (D) (closed sym-
bols).
Fig. 3. Rpn4 mediates transcriptional up-regulation of proteasome
gene expression in proteasome-deﬁcient umpmutants. A: mRNA levels
of proteasome subunit genes and UBI4 detected by Northern blotting.
B: Quantiﬁcation of the results shown in (A). Signals were normalized
to those of ACT1. mRNA values in mutant strains were calculated
relative to those in wt, which were set to 1.
M.K. London et al. / FEBS Letters 567 (2004) 259–264 263overloading of the proteasome with high levels of abnormal
proteins resulting from the incorporation of canavanine into
newly synthesized polypeptides.
It was reported recently that aside of the genes mentioned
Rpn4 controls, directly or indirectly, the expression of more
than 700 genes, most of which are associated with responses to
a variety of stresses [17]. A large group of these Rpn4-con-
trolled genes is involved in DNA damage repair. This and
earlier studies suggested a link of DNA damage repair and the
functions of the proteasome [18–20]. Consistent with these
studies, we observed that ump as well as rpn4 mutants were
hypersensitive to the DNA damage inducing drug MMS
(Fig. 5A). This prompted us to ask whether and how the re-
sponses to DNA damage and the control of proteasome levels
by Rpn4 are connected. Western-blot analysis showed that
after addition of 0.1% MMS, the cells immediately responded
by increasing the steady state level of Rpn4 protein. This isapparently due to a striking increase of RPN4 mRNA
(Fig. 5B). At the same time the stability of Rpn4 protein was
unaﬀected (Fig. 5C). An increase in transcription of protea-
some subunit genes after MMS treatment was detected as a
consequence of the elevated levels of Rpn4 (Fig. 5B). Rpn4
itself has been reported to be positively regulated by the
transcription factors Pdr1, Pdr3 and Yap1 that mediate mul-
tidrug and oxidative stress resistance [21]. Interestingly, YAP1
itself was reported to contain a PACE sequence in its promoter
Fig. 5. Rpn4 mediates the up-regulation of the proteasome in response
to DNA damage. A: rpn4-D and ump mutant strains are hypersensitive
to the DNA damaging drug methyl methanesulfonate (MMS). Serial
dilutions of cells were spotted onto plates containing yeast rich me-
dium with or without MMS and incubated for 2 days at 30 C. B:
Induction of Rpn4 and the proteasome after MMS treatment. Strain
ML26-2B (Rpn4-ha) was grown to mid-logarithmic phase in YPD.
The culture was divided and 0.1% MMS added to one half. Cells were
withdrawn at the indicated time points and levels of Rpn4-ha protein
analyzed by anti-ha Western blotting. RPN4 and PRE8 (encoding
proteasome subunit a2) mRNA levels were analyzed by Northern
blotting. C: Rpn4-ha stability was assayed after shutting oﬀ expression
with cycloheximide 10 min after addition of MMS.
264 M.K. London et al. / FEBS Letters 567 (2004) 259–264[12] suggesting that, in a second level of regulation, the Rpn4
protein may positively regulate expression of its own gene in-
directly via induction of Yap1. It remains to be seen whether
the observed induction of Rpn4 transcription after MMS
treatment involves these transcription factors. Taken together,
the data presented here demonstrated that Rpn4 is a sensor of
proteasome capacity that controls the levels of proteasomes
and of the UBI4 gene in response to defects and overloading of
the proteasome. In addition, Rpn4 mediates up-regulation of
proteasome synthesis in response to DNA damage as a con-
sequence of transcriptional induction of RPN4 itself. Up-reg-
ulation of proteasome gene expression has also been observed
after treatment of both yeast or mammalian cells with pro-teasome inhibitors, indicating that feedback regulation of
proteasomes occurs in both cell types [22,23]. For mammalian
cells, this response is of medical relevance as proteasome in-
hibitors are being tested as drugs in the treatment of diseases
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